Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Cetuximab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 26 Carcinoma, Non-Small-Cell Lung 16 Colonic Neoplasms 15 Lung Neoplasms 9 Rectal Neoplasms 8 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 6 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Oropharyngeal Neoplasms 5 Neoplasms 5 Solid Tumors 4 Gastrointestinal Neoplasms 3 Carcinoma, Pancreatic Ductal 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Melanoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Colorectal Cancer Metastatic 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Upper Gingival Squamous Cell Carcinoma 1

Interventions

11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡